The average revenue per capita in the 'Analgesics' segment of the otc pharmaceuticals market in Malaysia was forecast to continuously increase between 2024 and 2029 by in total 1.7 U.S. dollars (+41.98 percent). After the ninth consecutive increasing year, the average revenue per capita is estimated to reach 5.7 U.S. dollars and therefore a new peak in 2029.
Data provided by Statista Market Insights are estimates.
Definition: The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional information: The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included. For more information on the data displayed, use the info button next to the boxes.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Statista. (December 2, 2024). Revenue per capita of the analgesics market in Malaysia from 2018 to 2029 (in U.S. dollars) [Graph]. In Statista. Retrieved December 21, 2024, from https://www.statista.com/forecasts/1198966/average-revenue-per-capita-analgesics-malaysia
Statista. "Revenue per capita of the analgesics market in Malaysia from 2018 to 2029 (in U.S. dollars)." Chart. December 2, 2024. Statista. Accessed December 21, 2024. https://www.statista.com/forecasts/1198966/average-revenue-per-capita-analgesics-malaysia
Statista. (2024). Revenue per capita of the analgesics market in Malaysia from 2018 to 2029 (in U.S. dollars). Statista. Statista Inc.. Accessed: December 21, 2024. https://www.statista.com/forecasts/1198966/average-revenue-per-capita-analgesics-malaysia
Statista. "Revenue per Capita of The Analgesics Market in Malaysia from 2018 to 2029 (in U.S. Dollars)." Statista, Statista Inc., 2 Dec 2024, https://www.statista.com/forecasts/1198966/average-revenue-per-capita-analgesics-malaysia
Statista, Revenue per capita of the analgesics market in Malaysia from 2018 to 2029 (in U.S. dollars) Statista, https://www.statista.com/forecasts/1198966/average-revenue-per-capita-analgesics-malaysia (last visited December 21, 2024)
Revenue per capita of the analgesics market in Malaysia from 2018 to 2029 (in U.S. dollars) [Graph], Statista, December 2, 2024. [Online]. Available: https://www.statista.com/forecasts/1198966/average-revenue-per-capita-analgesics-malaysia